From a chemical pharmacy standpoint, Relafen 750 (Naproxen ) presents a fascinating case study in drug action. Its mechanism of function primarily involves the inhibition of cyclooxygenase (COX ) enzymes, particularly COX-2 , leading to a decrease in the synthesis of PGE2 . This targeted inhibition accounts for its anti-inflammatory characteristics